Merrion Pharmaceuticals: Appointment of Non-Executive Director
Merrion Pharmaceuticals plc, ("Merrion" or the "Company") today announced the appointment of Gerard Flood to its Board of Directors. Mr. Flood has an impressive track record in corporate finance and M&A transactions.
Mr Flood (60) was until 2009 a Partner in the KPMG Irish Practice for 25 years and Chairman of its Corporate Finance Division. Throughout his career, Gerard advised Public and Private Companies, State and Semi-State organisations in Merger and Acquisition activity, Fund raising, Project Finance, Corporate and Financial structuring and Strategy determination. Gerard was also an executive member of the KPMG Corporate Finance, Europe, Middle East and Africa Board which focused on the development of KPMG's involvement in cross border M&A and Project Finance assignments.
Commenting on the appointment Michael Donnelly, Executive Chairman, Merrion Pharmaceuticals said to-day, "We welcome Gerard Flood to the Merrion Board as an independent director. His M&A and corporate finance experience brings a valuable asset to the Merrion Board as it evaluates the value building strategies for the Merrion internal product pipeline and its partner programs."
Commenting on his appointment, Gerard Flood said, "I am pleased to be invited to join the Board of Merrion and I look forward to applying my experience to assisting the future development of the company"
The following are the directorships and partnerships held by Mr Flood within the past five years:
Antrich Consulting Limited, O'Dwyer Property Management Limited, Creagh Medical Limited, Global Shares Limited
Elkstone Limited, Reflex Plastics Technology Limited, KPMG Partnership.
Mr Flood was a Non-Executive Director to the following company which was placed into liquidation or receivership/administration: Reflex Plastics Technology Limited
There are no further details that are required to be disclosed pursuant to paragraph (g) of Schedule 2 ESM Rules.
Merrion Pharmaceuticals Plc.
T +353 1 642 3300
Davy Corporate Finance
T +353 1 679 6363
Posted: August 2013